The dual pandemics of COVID-19 and obesity: bidirectional impact

N Kapoor, S Kalra, W Al Mahmeed, K Al-Rasadi… - Diabetes Therapy, 2022 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the
COVID-19 pandemic, has been shown to disrupt many organ systems in the human body …

[HTML][HTML] Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

EL Presti, D Nuzzo, W Al Mahmeed, K Al-Rasadi… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Abstract Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease
(CVD) often cluster together as “Cardiometabolic Disease”(CMD). Just under 50% of …

COVID-19 causes ferroptosis and oxidative stress in human endothelial cells

SS Jankauskas, U Kansakar, C Sardu, F Varzideh… - Antioxidants, 2023 - mdpi.com
Oxidative stress and endothelial dysfunction have been shown to play crucial roles in the
pathophysiology of COVID-19 (coronavirus disease 2019). On these grounds, we sought to …

Promoting a syndemic approach for cardiometabolic disease management during COVID-19: The CAPISCO International Expert Panel

W Al Mahmeed, K Al-Rasadi, Y Banerjee… - Frontiers in …, 2021 - frontiersin.org
Efforts in the fight against COVID-19 are achieving success in many parts of the world,
although progress remains slow in other regions. We believe that a syndemic approach …

Neurological consequences, mental health, physical care, and appropriate nutrition in long-COVID-19

P Picone, T Sanfilippo, R Guggino, L Scalisi… - Cellular and Molecular …, 2023 - Springer
SARS-CoV-2 pandemic has caused a collapse of the world health systems. Now, vaccines
and more effective therapies have reversed this crisis but the scenario is further aggravated …

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis

M Nassar, H Abosheaishaa, AK Singh… - Journal of …, 2023 - Wiley Online Library
Background Patients with diabetes are more likely to suffer COVID‐19 complications. Using
noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved …

Circulating endothelial cells: a new possible marker of endothelial damage in Kawasaki disease, multisystem inflammatory syndrome in children and acute SARS …

M Fabi, B Petrovic, L Andreozzi, E Corinaldesi… - International Journal of …, 2022 - mdpi.com
Background: Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children
(MIS-C) are pediatric diseases characterized by systemic inflammation and vascular injury …

Antioxidant activity of citrus limonoids and investigation of their virucidal potential against SARS-CoV-2 in cellular models

F Magurano, M Sucameli, P Picone, M Micucci… - Antioxidants, 2021 - mdpi.com
The COVID-19 pandemic represents an unprecedented global emergency. Despite all
efforts, COVID-19 remains a threat to public health, due to the complexity of mass …

Non-insulin novel antidiabetic drugs mechanisms in the pathogenesis of COVID-19

T Salmen, VA Pietroșel, BM Mihai, IC Bica… - Biomedicines, 2022 - mdpi.com
The present study aimed to analyse the published data and to realize an update about the
use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 …

COVID-19 could worsen cerebral amyloid angiopathy

J Dewisme, T Lebouvier… - … of Neuropathology & …, 2023 - academic.oup.com
To the Editor: Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV2) is associated in 26–56% of cases with neurological …